Return to top of page

Alliance’s Bens Will Testify on MDUFA and PDUFA Reauthorization

April 3, 2017   |   Alliance for Aging Research Team   |   FDA & Regulatory Policy, Patient-focused Drug Development
Alliance’s Bens Will Testify on MDUFA and PDUFA Reauthorization

On April 4, the Alliance for Aging Research’s Vice President of Public Policy Cynthia Bens will testify before the U.S. Senate Committee on Health, Education, Labor, and Pensions about the reauthorization of the Medical Device User Fee Act (MDUFA) and Prescription Drug User Fee Act (PDUFA).

PDUFA authorizes the U.S. Food and Drug Administration (FDA) to collect fees from companies that produce specific drug and biological products. The reauthorization of PDUFA will allow for timely review in the approval process for new products.

To watch the full committee hearing and to hear Bens’ testimony, visit this website for live video.

Last week, Bens testified before the U.S. House of Representatives’ Energy and Commerce Committee, Subcommittee on Health, on reauthorization of the MDUFA.

Bens’ complete testimony from last week’s hearing can be found here. Her testimony, which begins at 1:56:00, can also be viewed below.

Candid Seal of Platinum Transparency 2022

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator logo

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.